119 related articles for article (PubMed ID: 8638923)
21. Stable expression of human cytochrome P450 3A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 Chinese hamster cells.
Schneider A; Schmalix WA; Siruguri V; de Groene EM; Horbach GJ; Kleingeist B; Lang D; Böcker R; Belloc C; Beaune P; Greim H; Doehmer J
Arch Biochem Biophys; 1996 Aug; 332(2):295-304. PubMed ID: 8806738
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities.
Nakajima M; Tane K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
J Pharm Sci; 2002 Apr; 91(4):952-63. PubMed ID: 11948533
[TBL] [Abstract][Full Text] [Related]
23. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
Chun YJ; Shimada T; Guengerich FP
Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
[TBL] [Abstract][Full Text] [Related]
24. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity.
Wan J; Imaoka S; Chow T; Hiroi T; Yabusaki Y; Funae Y
Arch Biochem Biophys; 1997 Dec; 348(2):383-90. PubMed ID: 9434752
[TBL] [Abstract][Full Text] [Related]
25. Characterization of dextromethorphan O- and N-demethylation catalyzed by highly purified recombinant human CYP2D6.
Yu A; Dong H; Lang D; Haining RL
Drug Metab Dispos; 2001 Nov; 29(11):1362-5. PubMed ID: 11602510
[TBL] [Abstract][Full Text] [Related]
26. Interaction of terfenadine and its primary metabolites with cytochrome P450 2D6.
Jones BC; Hyland R; Ackland M; Tyman CA; Smith DA
Drug Metab Dispos; 1998 Sep; 26(9):875-82. PubMed ID: 9733666
[TBL] [Abstract][Full Text] [Related]
27. V79 Chinese hamster cells genetically engineered for polymorphic cytochrome P450 2D6 and their predictive value for humans.
Krebsfaenger N; Mürdter TE; Zanger UM; Eichelbaum MF; Doehmer J
ALTEX; 2003; 20(3):143-54. PubMed ID: 12947487
[TBL] [Abstract][Full Text] [Related]
28. High-level expression of biologically active human prolactin from recombinant baculovirus in insect cells.
Das T; Johns PW; Goffin V; Kelly P; Kelder B; Kopchick J; Buxton K; Mukerji P
Protein Expr Purif; 2000 Nov; 20(2):265-73. PubMed ID: 11049750
[TBL] [Abstract][Full Text] [Related]
29. Comparison of catalytical activity and stereoselectivity between the recombinant human cytochrome P450 2D6.1 and 2D6.10.
Kong LM; Qian MR; Hu HH; Xu SY; Yu LS; Jiang HD; Chen SQ; Zeng S
Pharmazie; 2012 May; 67(5):440-7. PubMed ID: 22764579
[TBL] [Abstract][Full Text] [Related]
30. Recombinant production of human microsomal cytochrome P450 2D6 in the methylotrophic yeast Pichia pastoris.
Dietrich M; Grundmann L; Kurr K; Valinotto L; Saussele T; Schmid RD; Lange S
Chembiochem; 2005 Nov; 6(11):2014-22. PubMed ID: 16222729
[TBL] [Abstract][Full Text] [Related]
31. [Heterologous expression of functionally active human cytochrome P-450. I. Synthesis of cytochrome P-450IID6 by transformed Saccharomyces cerevisiae cells].
Krynetskiĭ EIu; Kovaleva IE; El'darov MA; Luzikov VN
Mol Biol (Mosk); 1993; 27(5):1094-9. PubMed ID: 8246932
[TBL] [Abstract][Full Text] [Related]
32. Baculovirus expression and purification of human and rat cytochrome P450 2E1.
Chen W; Peter RM; McArdle S; Thummel KE; Sigle RO; Nelson SD
Arch Biochem Biophys; 1996 Nov; 335(1):123-30. PubMed ID: 8914842
[TBL] [Abstract][Full Text] [Related]
33. Functional properties of CYP2D6 1 (wild-type) and CYP2D6 7 (His324Pro) expressed by recombinant baculovirus in insect cells.
Evert B; Eichelbaum M; Haubruck H; Zanger UM
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):309-18. PubMed ID: 9089660
[TBL] [Abstract][Full Text] [Related]
34. Role of murine cytochrome P-450 2F2 in metabolic activation of naphthalene and metabolism of other xenobiotics.
Shultz MA; Choudary PV; Buckpitt AR
J Pharmacol Exp Ther; 1999 Jul; 290(1):281-8. PubMed ID: 10381788
[TBL] [Abstract][Full Text] [Related]
35. Establishment of a novel host, high-red yeast that stably expresses hamster NADPH-cytochrome P450 oxidoreductase: usefulness for examination of the function of mammalian cytochrome P450.
Ohgiya S; Goda T; Hoshino T; Kamataki T; Ishizaki K
Arch Biochem Biophys; 1997 Jul; 343(2):215-24. PubMed ID: 9224733
[TBL] [Abstract][Full Text] [Related]
36. Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6. Lack of an allosteric role of NADPH-cytochrome P450 reductase in catalytic regioselectivity.
Hanna IH; Krauser JA; Cai H; Kim MS; Guengerich FP
J Biol Chem; 2001 Oct; 276(43):39553-61. PubMed ID: 11509577
[TBL] [Abstract][Full Text] [Related]
37. Optimization of an in vivo plant P450 monooxygenase system in Saccharomyces cerevisiae.
Jiang H; Morgan JA
Biotechnol Bioeng; 2004 Jan; 85(2):130-7. PubMed ID: 14704995
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Anopheles minimus CYP6AA3 expressed in a recombinant baculovirus system.
Boonsuepsakul S; Luepromchai E; Rongnoparut P
Arch Insect Biochem Physiol; 2008 Sep; 69(1):13-21. PubMed ID: 18615616
[TBL] [Abstract][Full Text] [Related]
39. cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus.
Buters JT; Korzekwa KR; Kunze KL; Omata Y; Hardwick JP; Gonzalez FJ
Drug Metab Dispos; 1994; 22(5):688-92. PubMed ID: 7835218
[TBL] [Abstract][Full Text] [Related]
40. Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity.
Smith G; Modi S; Pillai I; Lian LY; Sutcliffe MJ; Pritchard MP; Friedberg T; Roberts GC; Wolf CR
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):783-92. PubMed ID: 9560305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
